Home › Trial NCT02540824
Study of Apatinib in RET Fusion Positive Advanced Non-small Cell Lung Cancer
- Trial IDNCT02540824
- StatusUnknown
- PhasePhase 2
- Study typeInterventional
- SponsorTongji University
- Enrollment40
- Start date2015-01
- ConditionsNon-small Cell Lung Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.